We are live on ! Find out more
Qube Research & Technologies (QRT)

Qube Research & Technologies (QRT) Portfolio holdings

AUM $89.9B
1-Year Est. Return 20.22%
This Fund
S&P 500
This Quarter Est. Return
+6.68%
1 Year Est. Return
+20.22%
3 Year Est. Return
+42.42%
5 Year Est. Return
+23.97%
10 Year Est. Return
–
AUM
$18.7B
AUM Growth
+$1.89B
Cap. Flow
+$1.31B
Cap. Flow %
7.02%
Top 10 Hldgs %
10.01%
Holding
3,237
New
779
Increased
845
Reduced
690
Closed
834

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$109M
2
NCLH icon
Norwegian Cruise Line
NCLH
+$105M
3
GS icon
Goldman Sachs
GS
+$104M
4
VRTX icon
Vertex Pharmaceuticals
VRTX
+$101M
5
STLD icon
Steel Dynamics
STLD
+$99.4M

Top Sells

Rank Stock Value
1
CVX icon
Chevron
CVX
+$176M
2
KO icon
Coca-Cola
KO
+$151M
3
AVGO icon
Broadcom
AVGO
+$146M
4
MSFT icon
Microsoft
MSFT
+$140M
5
XOM icon
ExxonMobil
XOM
+$137M

Sector Composition

Rank Sector Weight
1 Technology 16.93%
2 Industrials 11.65%
3 Consumer Discretionary 11.56%
4 Healthcare 11.56%
5 Financials 11.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HARP
3151
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
– –
-1,489
Closed -$14K
FOCS
3152
DELISTED
Focus Financial Partners Inc. Class A
FOCS
– –
-7,419
Closed -$234K
ARNC
3153
DELISTED
Arconic Corporation
ARNC
– –
-43,805
Closed -$746K
MTEM
3154
DELISTED
Molecular Templates, Inc.
MTEM
– –
-1,738
Closed -$20K
LTCH
3155
DELISTED
Latch, Inc. Common Stock
LTCH
– –
-10,441
Closed -$10K
HGEN
3156
DELISTED
HUMANIGEN, INC.
HGEN
– –
-38,691
Closed -$7K
NMTR
3157
DELISTED
9 Meters Biopharma
NMTR
– –
-11,767
Closed -$51K
ISEE
3158
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
– –
-177,193
Closed -$3.18M
SQZ
3159
DELISTED
SQZ Biotechnologies Company
SQZ
– –
-17,679
Closed -$40K
USX
3160
DELISTED
U.S. Xpress Enterprises, Inc. Class A Common Stock
USX
– –
-22,329
Closed -$55K
ONCR
3161
DELISTED
Oncorus, Inc.
ONCR
– –
-15,874
Closed -$13K
TCRR
3162
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
– –
-23,431
Closed -$42K
SGTX
3163
DELISTED
Sigilon Therapeutics, Inc. Common Stock
SGTX
– –
-781
Closed -$5K
ABB
3164
DELISTED
ABB Ltd
ABB
– –
-9,607
Closed -$247K
SUMO
3165
DELISTED
Sumo Logic, Inc. Common Stock
SUMO
– –
-46,420
Closed -$348K
MAXR
3166
DELISTED
Maxar Technologies Inc. Common Stock
MAXR
– –
-25,722
Closed -$482K
FRC
3167
DELISTED
First Republic Bank
FRC
– –
-119,610
Closed -$15.6M
CDAK
3168
DELISTED
Codiak BioSciences, Inc. Common Stock
CDAK
– –
-10,421
Closed -$8K
IAA
3169
DELISTED
IAA, Inc. Common Stock
IAA
– –
-48,585
Closed -$1.55M
SFT
3170
DELISTED
Shift Technologies, Inc. Class A Common Stock
SFT
– –
-4,518
Closed -$32K
FPAC
3171
DELISTED
Far Peak Acquisition Corporation
FPAC
– –
-881,519
Closed -$8.72M
RUBY
3172
DELISTED
Rubius Therapeutics, Inc
RUBY
– –
-38,225
Closed -$17K
COUP
3173
DELISTED
Coupa Software Incorporated
COUP
– –
-8,186
Closed -$481K
ATNX
3174
DELISTED
Athenex, Inc. Common Stock
ATNX
– –
-3,532
Closed -$19K
GSQD
3175
DELISTED
G Squared Ascend I Inc.
GSQD
– –
-610,090
Closed -$6.05M
125 126
127
128 129

Similar funds

Focus Partners Wealth
Focus Partners Wealth Boston, Massachusetts $89.9B AUM 20.5% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $92.9B AUM 36.98% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return
Cetera Investment Advisers
Cetera Investment Advisers Schaumburg, Illinois $94B AUM 20.14% 1-Year Est. Return
Mariner
Mariner Overland Park, Kansas $85.7B AUM 24.21% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
California State Teachers Retirement System (CalSTRS)
California State Teachers Retirement System (CalSTRS) West Sacramento, California $94.5B AUM 29.33% 1-Year Est. Return

Qube Research & Technologies (QRT)'s Q4 2022 Portfolio in Review

As of Q4 2022, Qube Research & Technologies (QRT) held 3,237 positions worth $18.7B, up 11% from $16.8B the previous quarter. Its ten largest holdings account for 10% of the portfolio.

Qube Research & Technologies (QRT) deployed $1.31B of net new capital in Q4 2022, opening 779 new positions and adding to 845 existing holdings. Its largest new stake was Bristol-Myers Squibb: 1,451,017 shares worth $104M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 21% a quarter earlier, followed by Industrials and Consumer Discretionary.

On the sell side, the largest reduction was Microsoft, an estimated $140M trimmed.

  • Qube Research & Technologies (QRT)'s largest Q4 2022 buy was Bristol-Myers Squibb: 1,451,017 shares worth $104M.
  • Qube Research & Technologies (QRT) added most to Goldman Sachs in Q4 2022, an estimated $104M increase.
  • Qube Research & Technologies (QRT)'s biggest Q4 2022 reduction was Microsoft, cutting an estimated $140M.
  • Qube Research & Technologies (QRT) fully exited Chevron in Q4 2022, selling an estimated $176M.
  • Qube Research & Technologies (QRT)'s ten largest holdings make up 10% of its $18.7B portfolio in Q4 2022.
  • Qube Research & Technologies (QRT) opened 779 new positions and closed 834 in Q4 2022.
  • Qube Research & Technologies (QRT)'s portfolio value rose 11% quarter-over-quarter to $18.7B.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q4 2022, filed 14 Feb 2023.